StockLearn from Clustermicro · Stock Breakout ScannerStockLearn
← US stocks and world indices

Abbott Laboratories (ABT)

US-listed stock · Healthcare · Health Care Equipment · close 17 Nov 2026
Close
$104.71
Day change
-2.6%
1 month
-0.2%
6 months
+24.0%
1 year
-19.5%
3 years
+5.2%
5 years
-18.6%
From 52-week high
-19.5%
Weinstein stage
Stage 2
advancing
Abbott Laboratories closed at $104.71 on 17 Nov 2026. Over the past year it has lost 19.5%, and over five years -19% in all (-4.0% a year). It is 19.5% below its 52-week closing high of $130.03, set on 17 Nov 2025, and 26.8% above its 52-week closing low of $82.56. The price is above its 200-day average of $101.52 - an average that has been falling over the past month. On Stan Weinstein's stage analysis it is in Stage 2: advancing - above a rising 150-day average. Its deepest fall from a peak in the period shown was 42%. At that price it trades at 38.7 times its last twelve months' earnings ($2.70 a share, to 30 Sep 2026); net income changed -66% on a year earlier. On revenue of $48.2B (+10.0% on a year earlier), the net margin was 9.7%.

Valuation and profitability

Market value
$182.0B
P/E (TTM)
38.7
Price / book
3.6
Net margin
9.7%
Return on equity
9.2%
Revenue growth
+10.0%
Net income growth
-66%

From the company's SEC filings: the last twelve months to 30 Sep 2026, built from its 10-K and 10-Q reports. P/E and market value use the 17 Nov 2026 close, with the latest quarter's diluted share count; P/E is market value over net income, which stays right through a stock split. Growth compares with the twelve months a year earlier.

Price, RSI and MACD

Price · +18.5% over the period
8492101110119May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
RSI (14) · 45.5
305070
MACD (12, 26, 9) · histogram -0.51
-4.5-2.20.22.64.9
Price · -19.5% over the period
8093107121134Nov 25Jan 26Mar 26May 26Jul 26Sep 26Nov 26
RSI (14) · 45.5
305070
MACD (12, 26, 9) · histogram -0.51
-5.7-3-0.42.35
Price · -9.5% over the period
8197112128144Nov 24Mar 25Jul 25Nov 25Mar 26Jul 26Nov 26
RSI (14) · 45.5
305070
MACD (12, 26, 9) · histogram -0.51
-5.7-3-0.32.35
Price · +9.3% over the period
8197112128144Nov 23Apr 24Sep 24Feb 25Jul 25Dec 25May 26Oct 26
RSI (14) · 45.5
305070
MACD (12, 26, 9) · histogram -0.51
-5.5-2.9-0.32.45
Price · -18.1% over the period
8297113128144Aug 22May 23Feb 24Nov 24Aug 25May 26
RSI (14) · 45.5
305070
MACD (12, 26, 9) · histogram -0.51
-5.4-2.8-0.22.45
Price: daily close adjusted for stock splits, dashed line the 150-day moving average. MACD: green line, orange dashed signal, bars the histogram. Longer periods are drawn from every second or third session.

50-day average $103.88 · 200-day average $101.52 · 52-week closing range $82.56 – $130.03

Other Healthcare stocks

NameClose1M1Y5YP/EStage
Merck$143.37-1.8%+54.4%+73.6%144.82
Johnson & Johnson$278.70+9.1%+39.6%+70.7%42.42
Eli Lilly$1,415.55+12.6%+38.5%+442.0%45.92
Gilead Sciences$170.26+9.0%+37.2%+152.4%loss2
Regeneron Pharmaceuticals$957.76+21.1%+36.0%+49.2%21.02
Amgen$457.93+5.9%+34.0%+122.5%26.62
Elevance Health$433.93+1.3%+31.1%+1.0%18.42
Bristol Myers Squibb$61.35+2.7%+31.1%+3.2%13.62
McKesson$1,091.67+8.6%+27.6%+387.7%27.12
AbbVie$292.82+2.6%+25.1%+149.5%50.22
Vertex Pharmaceuticals$534.20+6.9%+23.1%+183.8%34.32
UnitedHealth$389.68-2.9%+21.6%-13.2%22.12
Thermo Fisher$686.79-0.5%+21.1%+7.8%36.02
Pfizer$28.47-3.8%+13.5%-44.0%40.62
CVS Health$85.81-7.1%+9.4%-7.5%10.03
Medtronic$102.32+8.0%+6.3%-13.2%25.12
HCA Healthcare$501.19+9.2%+5.0%+105.5%16.11
Danaher Corporation$225.77-1.4%+2.4%-17.8%36.82
Stryker Corporation$317.54+7.8%-11.8%+21.2%33.71
Intuitive Surgical$430.53+0.9%-21.3%+19.1%51.21

← All US stocks and world indices · NSE stocks

Daily closes to 17 Nov 2026, adjusted for stock splits (not dividends), from Google Finance and Yahoo Finance. US stock prices in US dollars; index levels in points. Figures may be delayed and are for information only.
For research & education only — not investment advice or a recommendation to buy or sell any security. StockLearn is an independent product of ClusterMicro Technologies, not affiliated with or endorsed by any exchange or index provider. ClusterMicro Technologies is not a SEBI-registered investment adviser. Consult a SEBI-registered adviser before investing.